128 results
Page 2 of 7
8-K
EX-99.1
46dtv
16 Nov 20
Innovation Pharmaceuticals Announces Overseas Regulatory Filing Submitted For COVID-19 Clinical Study
12:47pm
8-K
EX-99.2
1f61m0e
2 Nov 20
Regulation FD Disclosure
12:00pm
8-K
EX-99.1
2wsxnbfy2b82q4zuk5g
2 Nov 20
Regulation FD Disclosure
12:00pm
8-K
EX-99.1
ufkaa
2 Oct 20
Innovation Pharmaceuticals Announces Pre-IND Meeting Request Granted by FDA for the Study of Brilacidin for the Treatment of COVID-19
12:00pm
8-K
EX-99.1
6yr7w f2k
15 Sep 20
Laboratory Testing of Brilacidin for COVID-19 in Combination with Remdesivir Reduces Viral Load by Nearly 100 Percent
10:00am
424B5
bfvu4rn25ewo497 dv9p
4 Aug 20
Prospectus supplement for primary offering
9:32am
8-K
EX-99.1
nd8743kodkr q4zczsq9
4 Aug 20
Innovation Pharmaceuticals and U.S. Regional Biocontainment Laboratory Nearing Completion of Brilacidin Anti-SARS-CoV-2 (COVID-19) In Vitro Testing
9:29am
8-K
EX-99.1
5yvurlb7dy7spp4yg4r
22 Jul 20
Regulation FD Disclosure
10:00am
8-K
EX-99.1
vy40 26aztjfhmys
20 Jul 20
Regulation FD Disclosure
3:09pm
8-K
EX-99.1
5e30glph8
19 Jun 20
Regulation FD Disclosure
5:27pm
8-K
EX-99.1
gbhhtlrelw6czrsq8
26 May 20
Innovation Pharmaceuticals Receives Data from Public Health Research Institute Showing Brilacidin Inhibits SARS-CoV-2 (COVID-19) in a Human Cell Line
2:15pm
8-K
EX-99.1
f9ad um52tynvhy0h55x
21 May 20
Regulation FD Disclosure
9:32am
8-K
EX-99.2
khcic az2pid
21 May 20
Regulation FD Disclosure
9:32am
8-K
EX-99.1
qwjh5b zcue
28 Apr 20
Innovation Pharmaceuticals Informed Next Phase of Brilacidin Coronavirus (COVID-19) Testing to Begin Week of May 4
9:30am
8-K
EX-99.1
tsbs5eqdb30mm niaet
6 Apr 20
Regulation FD Disclosure
2:21pm
8-K
EX-99.1
x216rot1
1 Apr 20
Innovation Pharmaceuticals Receives Data Supporting Brilacidin’s Direct Inhibition of SARS-CoV-2, the Novel Coronavirus Responsible for COVID-19
12:00pm